Difference between revisions of "OctPGMSGp pathway control state"
From Bioblast
| Line 5: | Line 5: | ||
'''MitoPathway control state:''' FNSGp | '''MitoPathway control state:''' FNSGp | ||
'''SUIT protocol:''' [[ | '''SUIT protocol:''' [[SUIT-002]] | ||
This substrate combination supports convergent electron flow to the [[Q-junction]]. | This substrate combination supports convergent electron flow to the [[Q-junction]]. | ||
| Line 16: | Line 16: | ||
== OctPGMSGp(P) == | == OctPGMSGp(P) == | ||
:::[[SUIT-002]] | |||
:::[[SUIT-002 O2 mt D005]] | |||
:::[[SUIT-002 O2 pfi D006]] | |||
:::[[SUIT-002 O2 pce D007]] | |||
== OctPGMSGp(E) == | == OctPGMSGp(E) == | ||
::: | :::[[SUIT-002]] | ||
:::[[SUIT-002 O2 mt D005]] | |||
:::[[SUIT-002 O2 pfi D006]] | |||
:::[[SUIT-002 O2 pce D007]] | |||
Revision as of 11:50, 22 January 2019
- high-resolution terminology - matching measurements at high-resolution
OctPGMSGp pathway control state
Description
OctPGMSGp: Octanoylcarnitine & Pyruvate & Glutamate & Malate & Succinate & Glycerophosphate.
MitoPathway control state: FNSGp
SUIT protocol: SUIT-002
This substrate combination supports convergent electron flow to the Q-junction.
Abbreviation: OctPGMSGp
Reference: MiPNet21.06 SUIT reference protocol
MitoPedia concepts:
SUIT state
OctPGMSGp(L)
OctPGMSGp(P)
OctPGMSGp(E)
